Evaluation of an investigational wearable injector in healthy human volunteers
Sign Up to like & getrecommendations! Published in 2017 at "Expert Opinion on Drug Delivery"
DOI: 10.1080/17425247.2017.1252748
Abstract: ABSTRACT Objectives: Introduction of a wearable device for subcutaneous delivery of larger volume bolus injections would encourage patient compliance and reduce the burden on healthcare services. With one such wearable device commercially available, this study… read more here.
Keywords: fda cleared; investigational device; control devices; pain ... See more keywords
P021 Use of non-FDA cleared assays for detection of STIs in children being evaluated for suspected sexual abuse
Sign Up to like & getrecommendations! Published in 2019 at "Sexually Transmitted Infections"
DOI: 10.1136/sextrans-2019-sti.230
Abstract: Background Although NAAT testing is the gold-standard for C. trachomatis (Ct) and GC in adults, limited data exists for children. Although there are now 7 FDA cleared Ct/GC NAATs in the US, assays that are… read more here.
Keywords: suspected sexual; fda cleared; sexual abuse; evaluated suspected ... See more keywords
Performance characteristics of the first Food and Drug Administration (FDA)-cleared digital droplet PCR (ddPCR) assay for BCR::ABL1 monitoring in chronic myelogenous leukemia
Sign Up to like & getrecommendations! Published in 2022 at "PLoS ONE"
DOI: 10.1371/journal.pone.0265278
Abstract: Chronic myelogenous leukemia (CML) is a hematopoietic stem cell malignancy that accounts for 15–20% of all cases of leukemia. CML is caused by a translocation between chromosomes 9 and 22 which creates an abnormal fusion… read more here.
Keywords: myelogenous leukemia; bcr abl1; bcr; performance ... See more keywords